7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy
AssigneeOncoceutics, Inc.
InventorsMartin STOGNIEW, Joshua E. ALLEN
Life of this patent
Estimating the term…
Abstract
This disclosure relates, at least in part, to a method of treatment. In one embodiment, the method of treatment comprises administering to a subject in need of such treatment a first therapeutic agent including compound (1): or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent, wherein the first therapeutic agent and the second therapeutic agent are administered either simultaneously or sequentially.
Claims13
-37. (canceled)
A method of treatment, comprising administering to a subject in need of such treatment a therapeutic agent comprising compound (1):
- or a pharmaceutically acceptable salt thereof, wherein the treatment is for Multiple Myeloma.
-78. (canceled)
A method of treatment comprising administering to a subject having cancer in need of such treatment a pharmaceutically acceptable amount of compound (1):
- or a pharmaceutically acceptable salt thereof, wherein the pharmaceutically acceptable amount of compound (1) is administered as a salvage therapy.
-86. (canceled)
A method of treatment, comprising administering to a subject in need of such treatment a first therapeutic agent comprising compound (1):
- or a pharmaceutically acceptable salt thereof, wherein the treatment is for a genitourinary cancer.
Dependencies are inferred from the claim text.